Muscle, Bone and Vitamin D: Are There Connections?
|
|
- Damon Jones
- 5 years ago
- Views:
Transcription
1 Muscle, Bone and Vitamin D: Are There Connections? Endocrine Fellows Foundation, Sept 7, 2017 Neil Binkley, M.D. University of Wisconsin School of Medicine and Public Health Madison, WI, USA Disclosures Research support Amgen GE Healthcare Novartis Viking Consultant Amgen Radius Some of this talk is my opinion This is indicated by orange text Think, Don t Just Accept Dogma/Status Quo Only doubt is certain and disbelief worth believing. Without this courage there can be no learning. Believe nothing. Anonymous
2 Why Do You Treat Osteoporosis? Fracture is What s Important What is Osteoporosis? A systemic skeletal disease characterized by low bone mass and micro-architectural deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to fracture. Consensus Development Conference: Diagnosis, Prophylaxis, and Treatment of Osteoporosis. Am J Med. 1991; 90:107- This is Not Osteoporosis if the clinical diagnosis is limited to a T-score diagnosis, a great many patients at risk for fractures will have their risk go unrecognized. Shouldn t an older individual determined to be at high risk be diagnosed as having osteoporosis? Siris, et. al, Osteoporos Int; 2012, 23:
3 United HealthCare data; Proportion of patients in each quarter ( ) who received a BP or other osteoporosis med after hip fx n = 22,000+ Average age 72 68% female Less than 1 in 10 patients with hip fracture are being treated Kim, et. al., J Bone Min Res, 2016 DOI: /jbmr.2832 To draw an analogy from another field, in 2016 it is virtually inconceivable that a patient discharged from the hospital following a myocardial infarction would not be prescribed a full armamentarium of drugs for secondary cardiovascular prevention (eg, a statin, antihypertensive, and others). Yet what is inconceivable for a patient following a myocardial infarction is the norm in the vast majority of patients discharged from hospital after a hip fracture. Khosla and Shane, J Bone Min Res, 2016 DOI: /jbmr.2888 A Potential Approach to Improve the Osteoporosis Care Crisis Change the focus from osteoporosis to fracture Include ALL fractures in older adults Acknowledge that fractures affect QOL and independence Consider osteoporosis as just one part of a syndrome leading to fracture Need to address all components of the syndrome, not just the bones Binkley, et. al., J Bone Miner Res, :
4 Get Rid of the Fragility Fracture Concept Fragility Fracture, Osteoporosis-related Fracture, Lowtrauma Fracture, etc May Be Part of the Problem..we have demonstrated that there appeared to be nothing fragile about a fragility fracture based on patients communication of their fracture.. in other words, the term fragility or low trauma,...does not resonate with patients. Sale, et. al., Osteoporosis Int 2012, 23: Get Rid of the Fragility Fracture Concept Fragility Fracture, Osteoporosis-related Fracture, Lowtrauma Fracture, etc May Be Part of the Problem...even fractures occurring with intermediate or high trauma are predictive of recurrent fractures. As a result, we suggest that all fractures in older adults should be similarly evaluated for behaviors, risk factors and risk of recurrence that may benefit from interventions. Binkley, et. al., Submitted for publication 630 men and women over 8 years with a more than minimal trauma fracture More than minimal trauma defined as a force greater than minimal trauma but less than high trauma, e.g., MVA at > 30 km/h, falls from >4 m or significant physical assault Hand and foot fractures were included If age 50+, 55% had osteopenia and 23% osteoporosis.. We suggest that men and women over the age of 50 with a more-than-minimal trauma fracture should be investigated for low bone mass... Pereira, et. al., Osteoporos Int (2017) 28: DOI /s
5 Fractures = Need for Evaluation (Bone Attacks = Disease, Just Like Heart Attacks = Disease) I had a heart attack climbing stairs. I have high cholesterol and blockages in the arteries to my heart. I broke my falling down the stairs. It was an accident; anyone would have fractured if they fell like I did. We Need to State that Fractures Reduce Quantity and Quality of Life Need to Consider Osteoporosis as Part of a Syndrome Leading to Fracture; We Have Called this Dysmobility (Difficulty Walking) but the Name is Unimportant Rather than focusing on a single component, i.e., osteoporosis, sarcopenia, or obesity, an opportunity exists to combine clinical factors thereby allowing improved identification of older adults at risk Such a combination could be termed dysmobility syndrome. Binkley, et. al, Osteoporos Int, 2013: 24:
6 Focusing Only on Bone Identifies Less than Half of Women Who Will Fracture Only 44% of women (and 21% of men) who sustain non-vertebral fractures have osteoporosis by BMD 250 Number of non-vertebral fractures participants in the Rotterdam study; Mean follow-up 6.8 yrs FN BMD at baseline (Female data shown here) Normal BMD Osteopenia Osteoporosis Adapted from Schuit, Bone. 2004;34: Despite the Fact That Approximately 1/6 Fragility Fractures Occur in People With NORMAL BMD. Our Guidelines Call this Osteoporosis The diagnosis of osteoporosis is established by measurement of BMD or by the occurrence of adulthood hip or vertebral fracture in the absence of major trauma (such as a motor vehicle accident or multiple story fall). NOF Clinician s Guide: 2014 Does This Man Have Osteoporosis? History of fall with scalp laceration 2 months prior Severe knee OA, unable to arise from chair without using his arms Slipped in his garage with left hip fracture at age 66; BMI = 34.9 We Need to Think About More Than Just the Bones and Focus on Fracture L1-L g/cm 2 T-score = +6.4 FN g/cm 2 ; T-score = +0.9 TF g/cm 2 ; T-score = Radius g/cm 2 T-score = +1.9
7 It is Clear That Low Bone Density, i.e., Osteoporosis is Only Part of the Clinical Constellation that Contributes to What is Currently Called Osteoporosis-Related Fracture Think Beyond the Bone Chronologic Age is a Poor Predictor of Functional Status There must be a better way to estimate a patient s fracture risk than simply using age. Why Do Fractures Increase With Age? Multiple reasons. Falls become common with advancing age ~1/3 rd of adults age 65 and >40% over age 75 fall each year Many osteoporosis-related fractures due to falls Over 90% of hip fractures due to falls Rizzoli, et. al, Curr Med Res Opin, 25: , 2009 Guideline for falls prevention; AGS/BGS, JAGS 49: , 2001
8 Does Age Truly Affect Fracture Risk? Dubbo osteoporosis study; 3851 men and women age 60+ All fractures x-ray confirmed Measured BMD, body sway and quad strength Subjects with fracture have significantly higher body sway and lower muscle strength than subjects without fracture and, more importantly, that age alone has NO influence on the probability of fracture. Nguyen, et. al., BMJ, 1993, 307: Falls Risk Factors Predict Hip Fracture Independent of BMD These risk factors include History of falls } Self reported health Indicators of Self reported physical activity Slower walking speed Impaired Function Sarcopenia/Impaired Function Is What Actually Predicts Fracture Masud & Morris. 2001, Age & Ageing 30;Suppl 4:3-7 Geusens et. al., 2010, Therap Advances Musculoskel Dis 2:63-67 Impaired Physical Performance Increases Hip Fracture Risk Evaluated the association of physical performance and hip fracture risk in MrOS; 5995 men age 65+ Poor physical function is independently associated with an increased risk of hip fracture in older men. Adapted from Cawthon, et. al., J Bone Miner Res, 2008, 23:
9 Sarcopenia: the Age-related Gradual Loss of Muscle mass, Strength and Function Sarc for flesh (muscle), penia for deficiency Term coined in 1989; more recently defined as: The ageassociated loss of skeletal muscle mass and function. a complex syndrome associated with muscle mass loss alone or in conjunction with increased fat mass. Fielding, et. al, J Am Med Dir Assoc 2011; 12: There is No Single Consensus Definition of Sarcopenia at This Time All current definitions include a measure of lean mass and measure(s) of physical function Cruz-Jentoft, Age Aging, 2010, 39: Fielding, JAMDA, 2011, 12: Studenski, J Gerontol A Biol Sci Med Sci, 2014, 69: Osteoporosis Sarcopenia Pathogenesis is Multifactorial Hormonal declines GH/IGF-1, testosterone, estrogen Increased inflammation IL-6, TNF-alpha, etc, etc. Malnutrition Protein, vitamin D process? Sedentariness/Diseases leading to decreased use Toxin exposure Neuronal loss Reduced muscle bone quality expressed ultimately as reduced function Changes in structure, fat and connective tissue Are osteoporosis and sarcopenia the same With the disease being fracture? Jensen, J Parenter Enteral Nutr, 32; , 2008
10 Women With Hip Fracture Often Have Sarcopenia and Osteoporosis by DXA 313 white women with low-trauma hip fracture Sarcopenia; ALM/Ht 2 < 5.45 kg/m 2 Osteoporosis; Femur T-score -2.5 We show.. A significant association between sarcopenia and osteoporosis in a large sample of hip-fracture women. Data supports preventive strategies and treatment options for sarcopenia and osteoporosis targeting both bone and muscle Adapted from Di Monaco, et. al, Arch Gerontol Geriatr, 52; 71-71, 2011 Interdependency of Bone and Muscle is Not a New Concept The mechanostat model of bone regulation was described in 1960 by Dr. Frost in his Utah Paradigm Holds that bone growth and loss is stimulated by local mechanical elastic deformation of bone due to muscle force. More muscle, more strain, more bone Less muscle, less strain, less bone Frost H.M., The Utah Paradigm of Skeletal Physiology Vols 1 and 2, ISMNI, 1960 Frost, HM. J Bone Miner Metab. 2000; 18: Frost, H Anat Rec, 2003: A 275A: Mechanics drive tissue formation and regulate tissue repair. Although the previous scientific decade has yielded a virtual flood of insight into how mechanics control tissue-specific gene expression in these biological processes, the basic mechanisms behind mechanobiological regulation remain unclear. Snedekar, J, BoneKEy Reports, 2014 Article #: 562 doi: /bonekey ,
11 Even Bone + Muscle Isn t the Whole Story Obesity Increases Fracture Risk Global Longitudinal Study 60,393 women age 55 Followed for 2 years Our results demonstrate that obesity is not protective against fracture in postmenopausal women and is associated with increased risk of ankle and upper leg fractures. Compston, et al. Am J Med. 2011, 124: Too Little Bone, Too Little Muscle and Too Much Fat is Bad Should the Diagnosis be Osteo-Sarcobesity? Low Bone Mass Osteoporosis Low Muscle Mass Sarcopenia High Adipose Mass Obesity Dysmobility, i.e. Impaired Walking: This Also Allows Consideration of Other Things that Might Cause Difficulty in Walking or Increase Falls Risk, e.g., Balance, Neuropathy, etc, etc. Consider the Heart Attack Analogy Treatment is Directed at Various Conditions to Reduce Risk For a Potentially Catastrophic Outcome Metabolic Syndrome Advancing age Hyperlipidemia Hypertension Diabetes Obesity Family History Heart Attack Toxins, e.g., tobacco Reduced QOL Healthcare Cost Death
12 The Same Approach Makes Sense for Musculoskeletal Health, i.e., Bone Attack Treatment Should be Directed at Various Conditions to Reduce Risk For a Potentially Catastrophic Outcome Dysmobility Syndrome Advancing age Osteoporosis Sarcopenia Falls, Fractures Diabetes and Disability Obesity Family History Toxins, e.g., tobacco Reduced QOL Healthcare Cost Death NHANES data (n = 2975) assessed relationship between dysmobility and mortality in adults age 50+ Dysmobility was associated with increased mortality risk Additional work is needed to evaluate relationship with other outcomes Adapted from Looker A, Osteoporos Int 2015; 26: Dysmobility Syndrome Predicts Fractures Independent of FRAX Score 5,826 men in the MrOS cohort followed for a mean of 6.2 years ~7% had dysmobility defined as 3 of: Low BMD High fat mass Slow gait speed Low grip strength History of fall within past year Low ALM/ht 2 Dysmobility syndrome is an independent predictor of fracture, even when adjusted for FRAX score Buehring, et. al, presented at ASBMR 2016
13 Dysmobility Syndrome: An Important Concept but CLEARLY A WORK IN PROGRESS What factors to include requires further study: Arthritis? Multiple Fractures? Multiple and/or injurious falls Diabetes? Neuropathy? Balance Etc, etc Factors likely need to have different weights rather than simply being scored equally Dysmobility syndrome (as crudely defined) predicts mortality and falls Additional studies need to examine whether it predicts other health outcomes, e.g., falls and fractures Diabetes Almost Certainly Should be Included as a Risk Factor Manitoba, CA clinical data 3518 M/W age 50+ with, and without DM at Time of BMD testing Mean f/u 5.4 years Fx ascertained by ICD code FRAX underestimated observed major osteoporotic and hip fracture risk in diabetics. We conclude that diabetes confers an increased risk of fracture that is independent of FRAX derived with BMD. Giangregorio, et al, J Bone Miner Res, 2012, 27: Integrating Dsymobility Risk into FRAX is an Ideal Way to Facilitate Clinical Implementation Falls Sarcopenia Diabetes Symptomatic Osteoarthritis One year probability of falls (%) Any fall Injurious fall 75 28
14 We Do Not Require Calculators or Consensus: We Can Ask our Patients How many times have you fallen in the past year? Did any of these falls cause injury? Would you please stand up for me? If history of falls, particularly injurious falls and/or cannot arise without use of arms: Likely has dysmobility and is at increased risk for falls and fracture In Summary: THE HEALTH CONSEQUENCE OF IMPORTANCE IS FRACTURE Osteoporosis, Sarcopenia, Obesity, DM and Other Conditions are Part of the Fracture Risk Syndrome How Can We Take This to Clinical Care? Seems Likely That We Will Follow the Current Osteoporosis Paradigm Existing and Future Dysmobility Syndrome Treatments Look Like What We are Currently Calling Osteoporosis Treatment Nutrition Under-nutrition is common ~40% of hip fracture patients have energy/protein malnutrition Inadequate protein intake reduces muscle synthesis ~40% of older adults not meeting current RDA of 0.8 g/kg daily Protein intake of g/kg daily is likely optimal Calcium and Vitamin D Exercise/physical therapy/falls risk reduction Medications Hanger, et. al. N Z Med J ;112:88-90 Morley, J Nutr, Health, Aging, 12; , 2008 Mithal, et. al., Ost Int, 2013; doi /s y
15 The Bone Field Largely Has, and Continues, to Ignore Heaney s Guidance Heaney RP, Nutr Reviews 2013, 72:48-54 Robert Heaney, MD Virtually All Studies Fail to Recognize that Nutrients are Not the Same as Drugs Meta-analyses of flawed studies yield flawed conclusions Most Studies Fail to Recognize That We Are Not All The Same Binkley, et. al., currently unpublished Meta-analyses of flawed studies yield flawed conclusions
16 The IOM Recommends 1,000 mg of Calcium Daily Aged 19-50, 1200 mg Age 51+ And We Aren t Quite Getting There /Dietary-Reference-Intakes-for-Calcium-and- Vitamin- D/Vitamin%20D%20and%20Calcium%202010%20 Report%20Brief.pdf Manago KM et al. Calcium intake in the United States from dietary and supplemental sources across adult age groups: New estimate from the National Health and Nutrition Examination Survey , J Am Diet Assoc, 111: , The IOM Values are Consistent with Paleolithic Intake Paleolithic period > 2 million to ~10,000 years ago Humans began to cultivate plants and domesticate animals Hunter-gatherer diet consisted of: Animal source foods Lean meats, organs, bone marrow Uncultivated plants Fruits, nongrains, vegetables, nuts Paleo diet for this study included honey, eggs, pineapple, lettuce, celery, tomatoes, almonds, tuna, turkey, pork, chicken, oranges Average Paleo calcium intake 800 mg/day ± 400 mg/day Frassetto, et. al., Eur J Clin Nutr 2009: 63; NOF and ASPC convened an expert panel to evaluate the effects of dietary and supplemental calcium on CVD based on existing peer-reviewed literature The NOF and ASPC adopt the position that there is moderate-quality evidence (B level) that calcium with or without vitamin D intake from food or supplements has no relationship (beneficial or harmful) with the risk for cardiovascular and cerebrovascular disease, mortality, or all-cause mortality in generally healthy adults at this time. calcium intake from food and supplements that does not exceed the tolerable upper level of intake (2000 to 2500 mg/d) should be considered safe from a cardiovascular standpoint. Kopecky, et. al., Ann Int Med 2016:165:
17 Calcium Summary: Sept 2017 Aim for 1,000-1,200 mg/day Ideally through diet (+ supplements if needed) Close to the Paleo diet One serving is ~250 mg It is possible to get too much of anything; the jury is still out regarding vascular events There is no best calcium supplement Don t spend $$$$ If supplements are needed they should be taken with a meal Personal opinion Vitamin D Likely Important for Bone & Muscle USPSTF and AGS recommend vitamin D to reduce falls risk Common sense; target the level of highly sun exposed people Mean 25(OH)D 46 ng/ml Luxwolda, et. al., B J Nutr, V 108 / Issue 09 / November 2012, pp Be Aware that Assay Variability Persists: VDSP Guidance for 25(OH)D Assays, < 10% CV True value = 30 ng/ml (75 nmol/l) SD CV 10% 9% 8% 7% 6% 5% 4% 3% 2% 1% SD 24.0 Acceptable With widespread adoption of VDSP proposed limits, a patients 25(OH)D result of 30 ng/ml is actually somewhere between ng/ml (60-90 nmol/l) 30 75
18 What to Do? Aim a Little High To Maintain Serum 25(OH)D of 20 ng/ml or 30 ng/ml Measured True Value Maintain Maximum 25(OH)D 20 ng/ml ~15 to ~ 25 ng/ml ~30 ng/ml 40 ng/ml 25(OH)D 30 ng/ml ~24 to ~36 ng/ml 40 ng/ml 50 ng/ml Recognize that the reported value may be low: with this approach, the maximum is likely to be ~40 to ~50 ng/ml, below that attainable by UV exposure Personal opinion Rarely Use 50,000 IU Doses of Vitamin D Human Physiology Expects Daily D 3 Input, Not Bolus Doses We don t really know what we are doing to vitamin D metabolism by providing huge, non-physiologic doses Heaney, et. al., Nutr Rev; 73(1):51 67, community dwelling women Age ,000 IU D 3 orally or placebo in fall or winter Falls and fractures 137 had 25(OH)D measured serially Median 25(OH)D ~50 ng/ml A temporal pattern of falls was observed with an increase only in the first 3 months annual oral administration of high-dose cholecalciferol results in an increased risk of falls and fractures. Sanders, et. al., JAMA, 303; , 2010
19 Vitamin D Summary: Sept 2017 The field is in chaos (and passionate). Vitamin D inadequacy (however defined) is common Vitamin D is cheap and virtually side effect free Can t pick a single dose to assure whatever you believe to be vitamin D adequacy Daily dosing makes physiologic sense Ancestral human 25(OH)D mean is ~ 40 ng/ml Our current 25(OH)D measurements are imperfect Assay improvements are needed; progress being made RCTs with better study designs need to be conducted; This is not happening yet; expect chaos to continue Some Older Adults Have Phosphorus Deficiency And It Might Matter When Using Bone Drugs Phosphorus intake <70% of RDA in 10% of women age 60+; 15% age 80+ Low intakes also indicate low protein and calcium intake Potential for phosphorus deficiency increases if taking calcium supplements and bone active Rx Several courses of action present themselves at this stage of our ignorance. Most obvious is to use a calcium phosphate supplement. Heaney, RP in Nutrition and Bone Health, eds Holick & Nieves 2014; p 387 Protein Intake Recommendations: European Society for Clinical Nutrition and Metabolism Many reasons for higher protein needs Deutz,et. al., Clin Nutr, 33, , 2014
20 Expert Group Recommendations For health older people, the diet should provide at least 1.0 to 1.2 g protein/kg body weight/day Not clear whether best spread across meals or as a large pulse Not clear that specific amino acids, e.g., leucine, are best For older people who are malnourished or at risk of malnutrition (acute or chronic illness) diet should provide g/kg/day with even higher intake if severe illness Deutz,et. al., Clin Nutr, 33, , 2014 A protein intake of g/kg of body weight per day is probably optimal for older adults Mithal,et. al., Osteoporos Int, 24, , 2013 Muscle Medications Might Ideally be Used After Illnesses/Events to Get Back to Baseline Bone Active Medications Are Extremely Well Studied and Documented to Reliably Reduce Fracture Risk by ~50% In People at High Risk for Fracture, Especially Those Who Have Recently Sustained a Fragility Fracture, BPs (or other osteoporosis medications) Should be Prescribed for 3-5 years
21 Why Stop After 3-5 Years?? We have filled the remodeling space From Heaney, J Bone Miner Res 1994;10: And hyper mineralized the bone % of the total measurments Which might increase microcracks Over time, the changes in material-level properties could potentially override the structural-level benefits of bisphosphonates PLA ALN Boivin and Meunier, J Musculoskel Neuron Interact 2002; 2: Allen and Burr, BoneKEy-Osteovision 2007 February; 4(2):49-60 AFF Incidence Increases With Duration of Bisphosphonate Exposure 1.8 million Kaiser Permanente enrollees 45 years of age Potential AFF identified by ICD-9 diagnosis and CPT procedure codes All radiographs reviewed 142 femur fractures met ASBMR criteria for AFF 128 (90%) had previous BP exposure 14 (10%) no prior BP exposure Age adjusted incidence rose with increasing duration of BP exposure AFF Incidence Rate Age-adjusted per 100,000/year) BP exposure (years) ~ 1.1 per 1000 pt yrs after 10 years Adapted from Dell RM, J Bone Miner Res, 2012;27: Long-Term Treatment Risk/Benefit Numbers from ASBMR Task Force Per 100,000 patients Rx; Yr 9-10 NO data that hip or wrist fractures are prevented 1470 vert fx prevented 113 AFF caused (assuming; incorrectly) that ALL AFF are caused by BP 26 cases of ONJ caused 1470/139 = 10.6 spine fractures prevented per AFF/ONJ case caused Adapted from Adler, et. al., J Bone Miner Res, 2016; 31:16-35
22 Comprehensive Care (Dysmobility Syndrome Treatment?) After Hip Fracture Reduces Mortality and NH Readmission 124 patients with hip fracture 12 mo of high-intensity weight lifting exercise and targeted treatment of balance, osteoporosis, nutrition, vitamin D/calcium, depression, cognition, vision, home safety, polypharmacy and social support vs. usual care Note: Usual care included inpatient orthogeriatric and allied health consultation followed by 6-12 weeks of standard inpatient/outpatient physical therapy. Mortality NH Re-admit ADL decline was less and fewer use of assistive devices The intervention reduced mortality, nursing home admissions and ADL dependency compared with usual care. Adapted from Singh, et. al, JAMDA, 13: 24-30, 2012 Dysmobility Syndrome What To Do Today? Recognize fracture (not just osteoporosis) as the problem May be fatal May lead to inability to live independently Can be prevented (or at least have the risk for another fracture reduced) Reflects a syndrome, not just osteoporosis ALL fractures after age 50 require consideration of evaluation It s not just I fell Personal opinion Dysmobility Syndrome What To Do Today? Reduce falls Ask How many times have you fallen in the past year? Observe gait, ask to stand up without use of arms The usual falls risk reduction strategies including a PT consult Recognize that obesity may increase risk Optimize calories, calcium, vitamin D and protein status 2,000 IU daily is a reasonable place to start Measure 25(OH)D in those with falls/fractures Consider nutritionist evaluation Use existing osteoporosis medications to treat the bones Personal opinion
23 Fracture is the Outcome of Importance Due to a Syndrome of Osteoporosis, Sarcopenia, Obesity, Diabetes and Other Factors We Need to Focus Not Just on Bone, But On the Patient Treat the Person, Not Just Their Bones The good physician treats the disease; the great physician treats the patient who has the disease. Sir William Osler Thank You
Dysmobility Syndrome The Future of Fracture Risk Reduction
Dysmobility Syndrome The Future of Fracture Risk Reduction Canadian Musculoskeletal Conference, October 15, 2016 Neil Binkley, M.D. University of Wisconsin School of Medicine and Public Health Madison,
More informationSarcopenia: The Future of Fracture Risk Reduction NAMS, October 11, Disclosures/Conflicts of Interest. Why Do You Treat Osteoporosis?
Sarcopenia: The Future of Fracture Risk Reduction NAMS, October 11, 2013 Neil Binkley, M.D. University of Wisconsin School of Medicine and Public Health Madison, WI, USA Disclosures/Conflicts of Interest
More informationDysmobility Syndrome The Future of Fracture Risk Reduction Santa Fe Bone Symposium, August, 2014
Dysmobility Syndrome The Future of Fracture Risk Reduction Santa Fe Bone Symposium, August, 2014 Neil Binkley, M.D. University of Wisconsin School of Medicine and Public Health Research support l l l l
More informationMuscle, Bone and Vitamin D: Are There Connections? EFF-ASBMR Fellows Forum September 15, 2016
Muscle, Bone and Vitamin D: Are There Connections? EFF-ASBMR Fellows Forum September 15, 2016 Neil Binkley, M.D. University of Wisconsin School of Medicine and Public Health Research support Amgen Eli
More informationOsteoporosis: An Overview. Carolyn J. Crandall, MD, MS
Osteoporosis: An Overview Carolyn J. Crandall, MD, MS Osteoporosis: An Overview Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Objectives Review osteoporosis
More informationWhere Are We At With Osteoporosis 2018? WWHF June Neil Binkley, M.D. University of Wisconsin School of Medicine and Public Health
Where Are We At With Osteoporosis 2018? WWHF June 2018 Neil Binkley, M.D. University of Wisconsin School of Medicine and Public Health Why Do We Treat Osteoporosis? Fracture is What s Important United
More informationLearning Objectives. Controversies in Osteoporosis Prevention and Management. Etiology. Presenter Disclosure Information. Epidemiology.
12:45 1:30pm Controversies in Osteoporosis Prevention and Management SPEAKER Carolyn Crandall, MD, MS Presenter Disclosure Information The following relationships exist related to this presentation: Carolyn
More informationUsing the FRAX Tool. Osteoporosis Definition
How long will your bones remain standing? Using the FRAX Tool Gary Salzman M.D. Director Banner Good Samaritan/ Hayden VAMC Internal Medicine Geriatric Fellowship Program Phoenix, Arizona Using the FRAX
More informationOsteoporosis: How to Manage Long- Term Use of Bisphosphonates AKA Now What? David E Feinstein, DO, CCD November 15 th, 2017
Osteoporosis: How to Manage Long- Term Use of Bisphosphonates AKA Now What? David E Feinstein, DO, CCD November 15 th, 2017 Introduction A fracture due to OP occurs every 3 seconds around the world. 1
More informationOrthopaedic Related Conditions Literature Review
Orthopaedic Related Conditions Literature Review Louis Cheung Department of Orthopaedics & Traumatology The Chinese University of Hong Kong From: mydesultoryblog.com General Facts of Skeletal Muscles 40
More informationLearning Objectives. Controversies in Osteoporosis Prevention and Management. Definition. Presenter Disclosure Information.
4 4:45 pm Controversies in Osteoporosis Prevention and Management SPEAKER Carolyn Crandall, MD, MS Presenter Disclosure Information The following relationships exist related to this presentation: Carolyn
More informationDisclosures. Diagnostic Challenges in Osteoporosis: Whom To Treat 9/25/2014
Disclosures Diagnostic Challenges in Osteoporosis: Whom To Treat Ethel S. Siris, MD Columbia University Medical Center New York, NY Consultant on scientific issues for: AgNovos Amgen Eli Lilly Merck Novartis
More informationPage 1. Diagnosis and Treatment of Osteoporosis: What s New and Controversial in 2018? What s New in Osteoporosis
Diagnosis and Treatment of Osteoporosis: What s New and Controversial in 2018? Douglas C. Bauer, MD Professor of Medicine and Epidemiology & Biostatistics University of California, San Francisco What s
More informationModule 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC
Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with
More informationDiagnosis and Treatment of Osteoporosis: What s New and Controversial in ? What s New in Osteoporosis
Diagnosis and Treatment of Osteoporosis: What s New and Controversial in 2018-19? What s New in Osteoporosis The crisis in treatment and compliance Douglas C. Bauer, MD Professor of Medicine and Epidemiology
More informationDiscovering prior fractures in your postmenopausal patient may be the LINK to reducing her fragility fracture* risk in the future.
Discovering prior fractures in your postmenopausal patient may be the LINK to reducing her fragility fracture* risk in the future. *A fragility fracture is defined as a fracture caused by minimal trauma,
More informationCASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS
4:30-5:15pm Ask the Expert: Osteoporosis SPEAKERS Silvina Levis, MD OSTEOPOROSIS - FACTS 1:3 older women and 1:5 older men will have a fragility fracture after age 50 After 3 years of treatment, depending
More informationAACE/ACE Osteoporosis Treatment Decision Tool
AACE/ACE Osteoporosis Treatment Decision Tool What is Osteoporosis? OSTEOPOROSIS is defined as reduced bone strength leading to an increased risk of fracture. Osteoporosis, or porous bones, occurs when
More informationOSTEOPOROSIS IN MEN. Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO
OSTEOPOROSIS IN MEN Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO DISCLOSURES Speakers Bureau: Amgen, Radius Consultant: Abbvie, Amgen, Janssen, Radius, Sanofi Watts NB et
More informationVitamin D: Conflict of Interest Statement Corporate. Outline 7/5/2016
Vitamin D: What s New and Not? Clifford J Rosen MD Maine Medical Center Research Institute rosenc@mmc.org Conflict of Interest Statement Corporate NO STOCKS or EQUITY Editor UpToDate, New England Journal
More informationBAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008
BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology
More informationCoordinator of Post Professional Programs Texas Woman's University 1
OSTEOPOROSIS Update 2007-2008 April 26, 2008 How much of our BMD is under our control (vs. genetics)? 1 2 Genetic effects on bone loss: longitudinal twin study (Makovey, 2007) Peak BMD is under genetic
More informationScreening Guidelines: Women
The Situation 1 in 2 postmenopausal women and 1 in 5 older men will have an osteoporosis-related fracture in their lifetimes Osteoporosis Definition NIH Consensus Conference A skeletal disorder characterized
More informationSkeletal Manifestations
Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes
More informationOsteoporosis: A Tale of 3 Task Forces!
Osteoporosis: A Tale of 3 Task Forces! Robert A. Adler, MD McGuire Veterans Affairs Medical Center Virginia Commonwealth University Richmond, Virginia, USA Disclosures The opinions are those of the speaker
More informationWho cares about fractures! is more important. October 3, 2014 CSIM Workshop Brian Wirzba, MD, FRCPC, FACP Clinical Professor Grey Nuns Hospital
Isn t Osteoporosis just a T Score less than 2.5?? Who cares about fractures! is more important. Why do I need to know this? October 3, 2014 CSIM Workshop Brian Wirzba, MD, FRCPC, FACP Clinical Professor
More informationVitamin D and Calcium Therapy: how much is enough
Vitamin D and Calcium Therapy: how much is enough Daniel D Bikle, MD, PhD Professor of Medicine VA Medical Center and University of California San Francisco DISCLOSURE Nothing to disclose 1 RECOMMENDATIONS
More informationBONE HEALTH BASICS. Promoting Healthy Bones: Sorting Out the Science. Learning Objectives. Guest Speaker
Copyright 11 by the Preventive Cardiovascular Nurses Association Promoting Healthy Bones: Sorting Out the Science Guest Speaker Robert P. Heaney, MD, FACP, FASN Professor and Professor of Medicine Creighton
More informationThe Endocrine Society Guidelines
Vitamin D and Calcium Therapy: how much is enough DISCLOSURE Daniel D Bikle, MD, PhD Professor of Medicine VA Medical Center and University of California San Francisco Nothing to disclose RECOMMENDATIONS
More informationChallenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA
Challenging the Current Osteoporosis Guidelines Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Whom to screen Which test How to diagnose Whom to treat Benefits
More informationPage 1. New Developments in Osteoporosis. What s New in Osteoporosis
New Developments in Osteoporosis Eliseo J. Pérez-Stable MD Professor of Medicine Division of General Internal Medicine Department of Medicine July 4, 2013 Declaration of full disclosure: No conflict of
More informationNutritional concepts for the prevention and treatment of osteoporosis: what, for whom, when? Objectives
Nutritional concepts for the prevention and treatment of osteoporosis: what, for whom, when? Bess Dawson-Hughes, MD Disclosures: Amgen, DSM, Nestle, Opko, Pfizer, Roche, Tricida Interrelationships of muscle
More informationManagement of postmenopausal osteoporosis
Management of postmenopausal osteoporosis Yeap SS, Hew FL, Chan SP, on behalf of the Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis,
More informationInterpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm
Interpreting DEXA Scan and the New Fracture Risk Assessment Algorithm Prof. Samir Elbadawy *Osteoporosis affect 30%-40% of women in western countries and almost 15% of men after the age of 50 years. Osteoporosis
More informationUpdates in Osteoporosis. I have no conflicts of interest. What Would You Do? Mrs. C. What s New in Osteoporosis. Page 1
Updates in Osteoporosis Jeffrey A. Tice, MD Associate Professor of Medicine Division of General Internal Medicine, University of California, San Francisco I have no conflicts of interest What s New in
More informationSarcopenia in older people
Sarcopenia in older people Timothy Kwok/Ruth Chan Department of Medicine and Therapeutics / Centre for Nutritional Studies Outline What is sarcopenia? How common is sarcopenia? Risk factors of sarcopenia
More informationJuly 2012 CME (35 minutes) 7/12/2016
Financial Disclosures Epidemiology and Consequences of Fractures Advisory Board: Amgen Janssen Pharmaceuticals Inc. Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Outline Osteoporotic
More informationOsteoporosis Update. Case 2. Case 1: Monday morning, 8:15
Osteoporosis Update Laura E. Ryan, MD Assistant Director for Special Programs Center for Women s Health Clinical Assistant Professor of Medicine Division of Endocrinology, Diabetes and Metabolism The Ohio
More informationStudiedag Geriatrie, Leuven Bewegen als geneesmiddel. Sarcopenie
Studiedag Geriatrie, Leuven 29-05-2018 Bewegen als geneesmiddel Sarcopenie Evelien Gielen MD PhD Dienst Geriatrie & Centrum voor Metabole Botziekten, UZ Leuven Overview Introduction Muscle ageing Evolving
More informationCalcium, Vitamin D and Bisphosphonates: Disclosures. Benefits, Risks and Drug Holiday. Calcium YES or NO? Calcium Bad News!!
Calcium, Vitamin D and Bisphosphonates: Benefits, Risks and Drug Holiday Disclosures I am disclosing financial relationships as follows: Global Advisory Boards: Amgen, Lilly, Merck, Novartis Research grants:
More information7/12/2016. Presenter Disclosure Information. The Other Half of the Fracture Equation: Fall Prevention and Management. Presentation Outline
Presenter Disclosure Information Edgar Pierluissi Division of Geriatrics Edgar Pierluissi, MD Acute Care for Elders Unit Zuckerberg San Francisco General Hospital July 21, 2016 OSTEOPOROSIS NEW INSIGHTS
More informationMILK. Nutritious by nature. The science behind the health and nutritional impact of milk and dairy foods
MILK Nutritious by nature The science behind the health and nutritional impact of milk and dairy foods Muscle mass maintenance in older people There is evidence to suggest a potential role for milk and
More informationFracture=Bone Attack:
Fracture=Bone Attack: Linking Hip Fractures to Osteoporosis Care Angela M. Cheung, MD, PhD, FRCPC Professor of Medicine, University of Toronto Potential Conflicts of Interests Industry Grants (to UHN)
More informationCurrent and Emerging Strategies for Osteoporosis
Current and Emerging Strategies for Osteoporosis I have nothing to disclose. Anne Schafer, MD Assistant Professor of Medicine Division of Endocrinology & Metabolism December 12, 2014 Outline Osteoporosis
More informationPage 1. Updates in Osteoporosis. I have no conflicts of interest. What is osteoporosis? What s New in Osteoporosis
Updates in Osteoporosis Jeffrey A. Tice, MD Professor of Medicine Division of General Internal Medicine, University of California, San Francisco I have no conflicts of interest What s New in Osteoporosis
More informationClosing the Care Gap in Osteoporosis ICE Conference 2015
Closing the Care Gap in Osteoporosis ICE Conference 2015 Pat McCarthy-Briggs RD, MHEd Thank You! What is osteoporosis? a systemic skeletal disease characterized by low bone mass and microarchitectural
More informationOsteoporosis Screening and Treatment in Type 2 Diabetes
Osteoporosis Screening and Treatment in Type 2 Diabetes Ann Schwartz, PhD! Dept. of Epidemiology and Biostatistics! University of California San Francisco! October 2011! Presenter Disclosure Information
More informationMeta-analysis: analysis:
1 Diabetes and TZDs: Risk Factors for Fracture Ann Schwartz, PhD Dept. of Epidemiology and Biostatistics University of California San Francisco July 2010 Osteoporosis CME Presenter Disclosure Information
More informationUnderstanding Vitamin D: To D or not to D? Anastassios G Pittas, MD MS Tufts Medical Center
Understanding Vitamin D: To D or not to D? Anastassios G Pittas, MD MS Tufts Medical Center D2dstudy.org pittas@d2dstudy.org Disclosure: NIH funding Popularity of vitamin D RESEARCH CONSUMERS 40000 Publications
More informationOsteoporosis Management
Osteoporosis Management Lisa Voss PA C, CCD Laura Frontiero NP C, CCD Kaiser Healthy Bones Program San Diego Disclosures: Nothing to disclose www.zazzle.com 1 Overview How to diagnose Osteoporosis FRAX
More informationCOPD-Related Musculoskeletal Disease. Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017
COPD-Related Musculoskeletal Disease Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017 A 60-year old man with COPD comes into your office for a routine office visit. He is a former
More informationPage 1. Current and Emerging Strategies What s New in Osteoporosis. Osteoporosis. What is Osteoporosis? Traditional Risk Factors for Fracture
Current and Emerging Strategies for Osteoporosis What s New in Osteoporosis Risk stratification Douglas C. Bauer, MD University of California, San Francisco Under recognition and poor compliance New potential
More informationOsteoporosis Management in Older Adults
Osteoporosis Management in Older Adults Angela M Cheung, MD, PhD, FRCPC, CCD Professor of Medicine, University of Toronto Disclosures Relationship with Commercial Entities: Honoraria from: Amgen, Eli Lilly,
More informationProtein Requirements for Optimal Health in Older Adults: Current Recommendations and New Evidence
DASPEN 2013 Aarhus, Denmark, May 3 2013 Protein Requirements for Optimal Health in Older Adults: Current Recommendations and New Evidence Elena Volpi, MD, PhD Claude D. Pepper Older Americans Independence
More informationClinician s Guide to Prevention and Treatment of Osteoporosis
Clinician s Guide to Prevention and Treatment of Osteoporosis Published: 15 August 2014 committee of the National Osteoporosis Foundation (NOF) Tipawan khiemsontia,md outline Basic pathophysiology screening
More informationObjectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING
Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING TIFFANY PAUL, APN, CNP, CCD Objectives: Review the diagnosis of Osteoporosis Describe the basics of a bone density exam Identify
More informationChanges in Skeletal Systems over the Lifespan. Connie M. Weaver, Ph.D. Purdue University
Changes in Skeletal Systems over the Lifespan Connie M. Weaver, Ph.D. Purdue University Disclosures Boards/Scientific Advisory Committees ILSI Showalter Pharmavite Grants NIH Dairy Research Institute Nestle
More informationPage 1. Current and Emerging Strategies for Osteoporosis. Osteoporosis Warm-Up: Which of the Following is True?
Current and Emerging Strategies for Osteoporosis Douglas C. Bauer, MD Professor of Medicine and Epidemiology & Biostatistics University of California, San Francisco No Disclosures Osteoporosis Warm-Up:
More informationDrug Intervals (Holidays) with Oral Bisphosphonates
Drug Intervals (Holidays) with Oral Bisphosphonates Rizwan Rajak Consultant Rheumatologist & Lead for Osteoporosis GP Postgraduate Meeting April 2018 Contents Case presentation Pathway for Bisphosphonate
More informationOsteoporosis. Overview
v2 Osteoporosis Overview Osteoporosis is defined as compromised bone strength that increases risk of fracture (NIH Consensus Conference, 2000). Bone strength is characterized by bone mineral density (BMD)
More informationFOR CONSUMERS AND PATIENTS
AVAILABILITY OF VITAMIN D FOR CONSUMERS AND PATIENTS Prof. Heike A. Bischoff-Ferrari, MD, DrPH Centre on Aging and Mobility, University of Zurich Dept. of Rheumatology, University Hospital Zurich Overview
More informationOsteoporosis update. Dr. Claire Vandevelde Consultant Rheumatologist, LTHT
Osteoporosis update Dr. Claire Vandevelde Consultant Rheumatologist, LTHT Outline Background BMD Tools for assessing fracture risk Case study Denosumab Treatment breaks BMD BMD predicts fracture risk but
More informationHas the science of supplementation reached the breakthrough point?
IADSA Annual Week 19-21 June 2018 The Food Supplement Sector: Evolution and Evaluation Has the science of supplementation reached the breakthrough point? Manfred Eggersdorfer PhD Professor for Healthy
More informationEndpoints And Indications For The Older Population
Endpoints And Indications For The Older Population William J. Evans, Head Muscle Metabolism Discovery Unit, Metabolic Pathways & Cardiovascular Therapy Area Outline Functional Endpoints and Geriatrics
More informationBeyond BMI: Nutritional Strategies to Manage Loss of Muscle Mass and Function in Hospital and Community Francesco Landi, MD, PhD
Beyond BMI: Nutritional Strategies to Manage Loss of Muscle Mass and Function in Hospital and Community Francesco Landi, MD, PhD Catholic University, Geriatric Center, Gemelli Hospital - Rome, Italy Disclosures
More informationOsteoporosis Treatment Overview. Colton Larson RFUMS October 26, 2018
Osteoporosis Treatment Overview Colton Larson RFUMS October 26, 2018 Burden of Disease Most common bone disease 9.9 million Americans + 43.1 million Americans have low bone mineral density (BMD) Stealthy
More informationDifferentiating Pharmacological Therapies for Osteoporosis
Differentiating Pharmacological Therapies for Osteoporosis Socrates E Papapoulos Department of Endocrinology & Metabolic Diseases Leiden University Medical Center The Netherlands Competing interests: consulting/speaking
More informationStefano Volpato. Diagnosi e Trattamento della Sarcopenia nell Anziano
Diagnosi e Trattamento della Sarcopenia nell Anziano Stefano Volpato Dipartimento di Scienze Mediche UNIFE & Dipartimento Medico ad Attività Integrata OSPFE Università di Ferrara - ex labore fructus -
More informationFractures: Epidemiology and Risk Factors. July 2012 CME (35 minutes) 7/24/ July12 1. Osteoporotic fractures: Comparison with other diseases
Financial Disclosures Fractures: Epidemiology and Risk Factors Research grants, speaking or consulting: Amgen, Lilly, Merck, Novartis, Radius Dennis M. Black, PhD Department of Epidemiology and Biostatistics
More informationTreatment of sarcopenia: latest developments. Dr Miles D Witham Clinical Reader in Ageing and Health University of Dundee.
Treatment of sarcopenia: latest developments Dr Miles D Witham Clinical Reader in Ageing and Health University of Dundee What s the point in treating sarcopenia? Sarcopenia is associated with a range of
More information9/26/2016. The Impact of Dietary Protein on the Musculoskeletal System. Research in dietary protein, musculoskeletal health and calcium economy
The Impact of Dietary Protein on the Musculoskeletal System Outline A. The musculoskeletal system and associated disorders Jessica D Bihuniak, PhD, RD Assistant Professor of Clinical Nutrition Department
More informationDietary intake patterns in older adults. Katherine L Tucker Northeastern University
Dietary intake patterns in older adults Katherine L Tucker Northeastern University Changes in dietary needs with aging Lower energy requirement Less efficient absorption and utilization of many nutrients
More informationRisk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study
Risk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study Heikki Kröger Kuopio Musculoskeletal Research Unit, University of Eastern Finland (UEF) Dept. of Orthopaedics, Traumatology
More informationClinical Treatment of Obesity in Older Women. Barbara Nicklas J. Paul Sticht Center on Aging
Clinical Treatment of Obesity in Older Women Barbara Nicklas J. Paul Sticht Center on Aging In my day, people died. In my day, people died. Trajectory of physical ability Functional Independence Impairment
More informationBONE HEALTH Dr. Tia Lillie. Exercise, Physical Activity and Osteoporosis
BONE HEALTH Dr. Tia Lillie Exercise, Physical Activity and Osteoporosis Food for thought... How old would you be if you didn t know how old you were? DEFINITION: Osteoporosis Osteoporosis (OP) is a disease
More informationCurrent and Emerging Approaches for Osteoporosis
Current and Emerging Approaches for Osteoporosis Douglas C. Bauer, MD Professor of Medicine and Epidemiology & Biostatistics University of California, San Francisco No Disclosures What s New in Osteoporosis
More informationDisclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck
Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Outline Fracture incidence and impact of fractures
More informationNutritional concerns of overweight / obese older persons. Gordon L Jensen, MD, PhD Dept Nutritional Sciences Penn State University
Nutritional concerns of overweight / obese older persons Gordon L Jensen, MD, PhD Dept Nutritional Sciences Penn State University Prevalence of obesity among older adults: NHANES 1999-2004 Sex Age (years)
More informationMen and Osteoporosis So you think that it can t happen to you
Men and Osteoporosis So you think that it can t happen to you Jonathan D. Adachi MD, FRCPC Alliance for Better Bone Health Chair in Rheumatology Professor, Department of Medicine Michael G. DeGroote School
More informationOsteoporosis Update. Greg Summers Consultant Rheumatologist
Osteoporosis Update Greg Summers Consultant Rheumatologist DEFINITION OSTEOPOROSIS is LOW BONE MASS (& micro-architectural deterioration) causing AN INCREASED RISK OF FRACTURE 23 years 82 years 23 y/o
More informationFragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey
Fragile Bones and how to recognise them Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey Osteoporosis Osteoporosis is a skeletal disorder characterised by compromised bone
More informationDownload slides:
Download slides: https://www.tinyurl.com/m67zcnn https://tinyurl.com/kazchbn OSTEOPOROSIS REVIEW AND UPDATE Boca Raton Regional Hospital Internal Medicine Conference 2017 Benjamin Wang, M.D., FRCPC Division
More informationIn addition to bone health, emerging science reveals a non-skeletal benefit of vitamin D for several other health outcomes.
Vitamin D AT A GLANCE Introduction Vitamin D comprises a group of fat-soluble compounds that are essential for maintaining the mineral balance in the body. The vitamin D form synthesized in humans is called
More informationRole of nutrition in promoting muscle health for healthy aging
Key highlights Role of nutrition in promoting muscle health for healthy aging Dieu Huynh Senior Lead, Clinical Research and Nutrition Science Abbott Nutrition R&D Asia-Pacific Center 11 2017 Importance
More informationDisclosures Fractures:
Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Research Funding: GlaxoSmithKline, Merck Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Outline Fracture incidence
More informationChapter 39: Exercise prescription in those with osteoporosis
Chapter 39: Exercise prescription in those with osteoporosis American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York:
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Osteoporosis- Do We Need to Think Beyond Bone Mineral Density? Dr Preeti Soni 1, Dr Shipra
More informationFractures: Epidemiology and Risk Factors. Osteoporosis in Men (more this afternoon) 1/5 men over age 50 will suffer osteoporotic fracture 7/16/2009
Fractures: Epidemiology and Risk Factors Mary L. Bouxsein, PhD Department of Orthopaedic Surgery Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA Outline Fracture incidence and impact
More informationFRAX, NICE and NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield
FRAX, NICE and NOGG Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield Disclosures Research funding and/or honoraria and/or advisory boards for: o ActiveSignal, Amgen, Bayer, Boehringer
More informationClinical Nutrition in the 21st Century Malnutrition, sarcopenia and cachexia
Clinical Nutrition in the 21st Century Malnutrition, sarcopenia and cachexia Stéphane M. Schneider, MD, PhD, FEBGH Professor of Nutrition and ESPEN ECPC Chair In proto-indo-european, Latin and Greek Under
More informationAACE Congress Symposium Boston, MA May 20, 2018
Bone Loss After Bariatric Surgery: Causes, Consequences and Management John P. Bilezikian, MD, PhD(hon), MACE Silberberg Professor of Medicine Vice-Chair for International Education and Research Chief,
More informationThe Paleolithic Diet. A Review
The Paleolithic Diet A Review by: Philip Rouchotas, MSc, ND Bolton Naturopathic Clinic 64 King St. W, Bolton, Ontario L7E 1C7 info@boltonnaturopathic.ca What is the Paleolithic Diet? Today s modern diet
More informationA Review of Bone Health Issues in Oncology
A Review of Bone Health Issues in Oncology David L. Kendler MD FRCPC CCD Professor of Medicine (Endocrinology) University of British Columbia Vancouver Canada Disclosures David Kendler has received research
More informationBETTER YOUR BONES UPDATE ON LATEST BONE HEALTH RESEARCH
BETTER YOUR BONES UPDATE ON LATEST BONE HEALTH RESEARCH Taylor C. Wallace, PhD, CFS, FACN Academy of Nutrition and Dietetics Food Nutrition Conference & Expo October 5 th, 2015 Disclosures Employment George
More informationESPEN Congress The Hague 2017
ESPEN Congress The Hague 2017 Altering lifestyle to improve nutritional status in older adults Nutritional interventions to prevent and treat frailty F. Landi (IT) Nutritional interventions to prevent
More informationSarcopenia una definicion en evolucion. Hélène Payette, PhD Centre de recherche sur le vieillissement
Sarcopenia una definicion en evolucion Hélène Payette, PhD Centre de recherche sur le vieillissement X Curso ALMA Cancun, Mexico, Julio 2011 NIA conference Epidemiologic and Methodologic Problems in Determining
More informationTask Force Co-Chairs. Members
Managing Osteoporosis Patients After Long-Term Bisphosphonate Treatment Report of a Task Force* of the American Society for Bone and Mineral Research Robert A. Adler, MD Task Force Co-Chairs Ghada El-Hajj
More informationOsteoporosis: A Tale of 3 Task Forces!
Osteoporosis: A Tale of 3 Task Forces! Robert A. Adler, MD McGuire Veterans Affairs Medical Center Virginia Commonwealth University Richmond, Virginia, USA Disclosures The opinions are those of the speaker
More informationAdvanced medicine conference. Monday 20 Tuesday 21 June 2016
Advanced medicine conference Monday 20 Tuesday 21 June 2016 Osteoporosis: recent advances in risk assessment and management Juliet Compston Emeritus Professor of Bone Medicine Cambridge Biomedical Campus
More informationBalancing the Risks and Benefits of Osteoporosis Treatment: part I: 3 to 5 years treatment
Balancing the Risks and Benefits of Osteoporosis Treatment: part I: 3 to 5 years treatment Dennis M. Black, PhD Department of Epidemiology and Biostatistics, UCSF Financial Disclosures (past 3 years) -Consulting
More information